The Future of Percutaneous Epicardial Interventions.
Epicardial
Innovation
Percutaneous
Pericardial
Journal
Cardiac electrophysiology clinics
ISSN: 1877-9190
Titre abrégé: Card Electrophysiol Clin
Pays: United States
ID NLM: 101549998
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
entrez:
11
8
2020
pubmed:
11
8
2020
medline:
29
6
2021
Statut:
ppublish
Résumé
The pericardial space provides a unique vantage point to access different cardiac structures for diagnosis and treatment of arrhythmias and other nonelectrophysiologic conditions, such as heart failure. There have been notable innovations to improve safety of percutaneous pericardial access and its use for various procedures. Percutaneous pericardial device therapies for pacing and defibrillation have been in development, success of which will be a significant advance in treatment of bradyarrhythmias, cardiac resynchronization therapy, and prevention of arrhythmic deaths. There is need for continued efforts in development and expansion of this technique and a systematic approach to monitor efficacy and safety outcomes.
Identifiants
pubmed: 32771195
pii: S1877-9182(20)30041-1
doi: 10.1016/j.ccep.2020.04.007
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
419-430Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure Drs R. Karki and A.M. Killu do not have financial disclosures relevant to this article. Dr P.A. Friedman is a coinventor of epicardial cooling technology licensed to MediCool, and epicardial leads.